Thymalin, sometimes referred to as Thymalin Alpha-1, is the synthetic variant of the endogenous Thymulin, which was first isolated from the thymus in 1977. The endogenously produced Thymalin has been researched for its potential in a wide landscape of research areas, with its influence speculated to extend to regulatory action on inflammation, mitigation of pain perception, neuroprotective action, and immune function support. Early studies have suggested that Thymalin and other thymus and pineal gland secretions may also support cell longevity.
